The global veterinary infusion pumps market size is expected to reach USD 427.79 million by 2030, registering a CAGR of 7.36% from 2023 to 2030, according to a new report by Grand View Research, Inc. An increasing pet population, prevalence of chronic diseases among animals, technological advancements in infusion therapy, and growing R&D initiatives are key drivers accelerating market demand. As per the European Pet Food Industry Federation (FEDIAF), in 2022, the pet population in Europe was more than 340 million in 2022 from over 305 million in 2021. Thus, the growing adoption of pets in developed regions and rising awareness regarding advanced infusion pumps owing to several advantages are a few aspects driving market demand.
The COVID-19 pandemic significantly affected the market. This included reduced access to veterinary services, disruption in the supply chain, temporary ban on imports and exports, shutdown of manufacturing units, and economic constraints on veterinary facilities. However, despite this, the market showed positive growth during the year 2021 owing to heightened awareness regarding preventative disease management for better pet care coupled with the growing adoption of infusion pumps among homecare settings for long-term disease management, and increased demand for telemedicine and remote monitoring platforms. Thus, the factors mentioned above propelled market demand.
Growing government initiatives for pet care, favorable regulatory scenarios, and rising research and development activities for novel drug innovations are some of the major factors driving the market growth. Further, the rising trend towards effective nutritional therapies such as enteral nutrition for animal care positively influences market revenue growth. Technological advancements in infusion pumps including the integration of wireless technology, several program modes for precise drug dosing, a multichannel mode for continuous administration of multiple medications simultaneously, and several others, will accelerate product adoption over the forecast period.
The strong presence of key market participants at the domestic, regional, and global levels actively focusing on the development, manufacturing, and commercialization of advanced veterinary infusion pumps for enhanced patient outcomes is propelling the overall market growth. For instance, in June 2023, B. Braun Melsungen AG launched DoseTrac, a next-generation infusion management software for real-time data monitoring and analysis for infusion pump operational data. This platform can connect up to 40,000 infusion pumps from different locations. Such advancements broadened the company's offerings in the significant market and offered a competitive edge over its peers.
Request a free sample copy or view report summary: Veterinary Infusion Pumps Market Report
Based on product type, the volumetric infusion pumps segment dominated the market in 2023 with a revenue share of 77%.This dominance can be attributed to the growing usage of large-volume infusion pumps for numerous benefits, including delivering fluids during animal blood transfusions, parenteral nutrition administration, and emergency conditions. The syringe infusion pumps segment is projected to grow at a substantial CAGR of about 6.87% over the forecast period
Based on animal type, the companion animals segment held the largest share in 2023. The livestock animals segment, on the other hand, is anticipated to grow at the fastest CAGR of over 8.45% in the forthcoming years
In 2023, by route of administration, the intravenous segment held the largest share of around 90.68% of the market.The subcutaneous route segment is expected to grow at the fastest CAGR of over 8.0% during the forecast period
In terms of application, the fluid therapy segment held the largest market share in 2023, while the nutrition segment is estimated to grow at the fastest CAGR of about 7.7% from 2024 to 2030
In terms of end-use, the veterinary hospitals & clinics segment garnered the largest market share of around 48.0% in 2023. While the home care segment is anticipated to witness the fastest CAGR over the forecast period
In 2023, North America held the largest regional share of more than 30.00% of the global market. Asia Pacific is anticipated to grow at a CAGR of about 8% owing to the strong presence of local players and rising pet population
Grand View Research has segmented the global veterinary infusion pumps market based on product type, animal type, route of administration, application, end-use, and region:
Veterinary Infusion Pumps Product Type Outlook (Revenue, USD Million, 2018 - 2030)
Volumetric Infusion Pumps
Syringe Infusion Pumps
Veterinary Infusion Pumps Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
Companion Animals
Livestock Animals
Veterinary Infusion Pumps Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
Intravenous (IV)
Subcutaneous
Epidural Infusion
Other Route of Administration
Veterinary Infusion Pumps Application Outlook (Revenue, USD Million, 2018 - 2030)
Fluid Therapy
Anesthesia
Pain Management
Nutrition
Other Application
Veterinary Infusion Pumps End-use Outlook (Revenue, USD Million, 2018 - 2030)
Veterinary Hospitals & Clinics
Home Care
Research & Academic Institutions
Other End-use
Veterinary Infusion Pumps Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Rest of Europe
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Middle East & Africa
South Africa
Saudi Arabia
UAE
Turkey
Kuwait
Rest of MEA
List of Key Players in the Veterinary Infusion Pumps Market
B. Braun Melsungen AG
Shenzhen Mindray Animal Medical Technology Co., LTD.
Avante Health Solutions
Burtons Medical Equipment
Digicare Biomedical Technology Inc.
Eitan Medical Ltd.
Grady Medical Systems
HESKA Corporation
Leading Edge Veterinary Equipment
Millpledge Veterinary
"The quality of research they have done for us has been excellent..."